RecruitingNCT07396662

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

The Analysis of Endocrine-exocrine Functions and Prognosis After Pancreatectomy


Sponsor

National Taiwan University Hospital

Enrollment

3,500 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Pancreatic diseases often require surgery or invasive procedures to provide a chance for a cure. However, due to the pancreas's unique anatomical structure, its relative position to adjacent organs, and its dual endocrine and exocrine functions, the complexity of surgery is increased, impacting the patient's postoperative quality of life. Therefore, this project aims to retrospectively collect basic data, preoperative and postoperative blood tests (blood cell counts, biochemistry, tumor markers, glucose-related, lipid-related), and preoperative and postoperative imaging examinations (CT, MRI, Ultrasound, PET scan, Endoscopy, etc.) of patients who underwent pancreatic surgery at our hospital. We aim to compare whether surgical methods, lesion margin clearance rates, and postoperative remnant pancreatic volume affect the patient's endocrine function, exocrine function, quality of life, and disease prognosis. This analysis is intended to understand the indications, surgery-related factors, and prognosis for patients planning to undergo pancreatic surgery, with the expectation of providing more diverse and specific treatment recommendations for patients with pancreatic diseases in the future


Eligibility

Min Age: 20 YearsMax Age: 75 Years

Inclusion Criteria1

  • All patients scheduled for pancreatectomy

Exclusion Criteria1

  • Age under 20 years or older than 75 years; Pregnancy

Interventions

PROCEDUREpancreatectomy

all procedures demanding pancreatic parenchyma transaction


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07396662


Related Trials